Opportunistic Infections: Clinical Trials

1 trial for Opportunistic Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow Opportunistic Infections: new trials by email Literature Review of Opportunistic Infections trials Research Report on Opportunistic Infections

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
Valganciclovir - Cytomegalovirus Retinitis, HIV Infections
Phase 3UnknownHoffmann-La Roche5002005-06-24

Narrower conditions

AIDS-Related Opportunistic Infections (1)  ·  Cytomegalovirus Retinitis (1)  ·  HIV Infections (1)

Broader conditions

Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Cytomegalovirus Infections (1)  ·  DNA Virus Infections (1)  ·  Eye Diseases (1)  ·  Eye Infections (1)  ·  Eye Infections, Viral (1)  ·  Genital Diseases (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  RNA Virus Infections (1)

Interventions

Valganciclovir (1)

Sponsors

Hoffmann-La Roche (1)

Countries

Puerto Rico (1)  ·  United States (1)